ArticleScientific reports2026
Predicting worsening visual field via masked dual stage attention recurrent neural network.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Based on dual-stage attention recurrent neural network (DA-RNN), a masked DA-RNN (MDA-RNN) model was developed to predict future visual fields (VF). The training dataset comprised 154,105 VF examinations of 22,404 eyes. Performance was measured as the mean absolute error (MAE) between the predicted and actual values of mean deviation (MD), pattern standard deviation (PSD), Visual Field Index (VFI), 54 values of total deviation values (TDV) according to glaucoma severity and the prediction interval. Attention weights were analyzed to determine the characteristics of the MDA-RNN. Prediction errors of MDA-RNN for MD, PSD, VFI, TDV were 1.44 ± 2.05 dB, 1.03 ± 1.09 dB, 4.19 ± 7.07%, and 2.45 ± 1.97 dB respectively. Except for the VFI error, MDA-RNN exhibited a significantly lower prediction error than the masked bidirectional gated recurrent unit (BiGRU) model. The MDA-RNN assigned large weights to the TDV, PDV, MD, and false negative ratio (FN) in the encoder attention. In decoder attention, high scores were assigned to VF with lower FN and higher MD. MDA-RNN focused more on important features and could select more reliable VFs over all time steps, reducing noise in the VF input. The MDA-RNN was robust in predicting severe glaucoma, largely worsening glaucoma, and offered long-term prediction intervals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.